Chronic Myeloid Leukemia News and Research

RSS
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. According to the American Cancer Society, CML is a type of cancer that starts in blood-forming cells of the bone marrow and then invades the blood. It can spread to the lymph nodes, spleen, liver, and other parts of the body. CML can also change into a fast-growing acute leukemia that invades almost any organ in the body.
Discovery may lead to potential new therapeutic approach to eradicate blood cancers

Discovery may lead to potential new therapeutic approach to eradicate blood cancers

Researchers identify drugs that may enhance ability of TKI dasatinib to kill human cancer cells

Researchers identify drugs that may enhance ability of TKI dasatinib to kill human cancer cells

PDL BioPharma signs revenue interest assignment agreement with ARIAD Pharmaceuticals

PDL BioPharma signs revenue interest assignment agreement with ARIAD Pharmaceuticals

New tool combines drugs to target kinase dependency in cancer

New tool combines drugs to target kinase dependency in cancer

UC San Diego, GSK collaborate to treat leukemia by eliminating cancer stem cells

UC San Diego, GSK collaborate to treat leukemia by eliminating cancer stem cells

Current treatments for blood cancer priced too high to be considered cost-effective, new analysis finds

Current treatments for blood cancer priced too high to be considered cost-effective, new analysis finds

NeoGenomics announces launch of new NeoLAB assays to diagnose hematologic diseases

NeoGenomics announces launch of new NeoLAB assays to diagnose hematologic diseases

US cancer physicians explore new approach to help older patients undergoing hematopoietic stem cell transplant

US cancer physicians explore new approach to help older patients undergoing hematopoietic stem cell transplant

Novartis to highlight strength of its expanded oncology portfolio at ASCO 2015

Novartis to highlight strength of its expanded oncology portfolio at ASCO 2015

Researchers discover how and where chromosome fragile sites occur in human DNA

Researchers discover how and where chromosome fragile sites occur in human DNA

Evolution of two protein kinases may hold key to unlocking highly specific cancer drugs

Evolution of two protein kinases may hold key to unlocking highly specific cancer drugs

Tissue and cell diagnostics market reaches $7.7 billion in 2014

Tissue and cell diagnostics market reaches $7.7 billion in 2014

Drug similar to Gleevec may help tame some brain cancers

Drug similar to Gleevec may help tame some brain cancers

Breakthrough therapies for blood cancers may provide reasonable value for money spent

Breakthrough therapies for blood cancers may provide reasonable value for money spent

Breakthrough blood cancer therapies may provide reasonable value for money spent

Breakthrough blood cancer therapies may provide reasonable value for money spent

Yale researcher receives 2015 Frontiers of Knowledge Award in Biomedicine

Yale researcher receives 2015 Frontiers of Knowledge Award in Biomedicine

Novel targeted therapies and treatment combinations for leukemia

Novel targeted therapies and treatment combinations for leukemia

Novartis to highlight advances in blood, breast cancer research at ASH and SABCS 2014

Novartis to highlight advances in blood, breast cancer research at ASH and SABCS 2014

Bristol-Myers Squibb, MD Anderson partner to evaluate multiple immunotherapies

Bristol-Myers Squibb, MD Anderson partner to evaluate multiple immunotherapies

Aptose joins Beat AML research collaboration

Aptose joins Beat AML research collaboration